2nd Edition of Cell & Gene Therapy World Conference(CGTWC) 2026

Scientific Sessions

Stem Cell Derived Therapeutics: iPSCs, Organoids and Tissue Engineering

Stem cell-derived therapeutics are redefining the frontiers of regenerative medicine, creating new approaches to tissue repair, replacement, and regeneration of damaged tissues. Progress in iPSCs, organoid technology, and tissue engineering is leading to innovations in personalized therapy, drug discovery, and disease modelling, and bringing us closer to the reality of restoring functional tissues.

At our Miami, Cell & Gene Therapy World Conference, preeminent researchers and translational experts will discuss recent advances in stem cell biology, scalable differentiation protocols, and bioengineering strategies to advance therapeutic specificity and reproducibility. The discussion also covers manufacturing standards, safety evaluations, and regulatory challenges that need to be addressed for successful clinical translation

Related Sessions

CRISPR Cas9 and Beyond: Emerging Genome Editing Platforms
Precision Genome Editing: From Target Discovery to Clinical Application
Engineering the Immune System: Gene and Cell Based Modulation
Non Viral Gene Delivery Strategies: Safety, Scalability, and Translation
Stem Cell Derived Therapeutics: iPSCs, Organoids and Tissue Engineering
Allogeneic vs Autologous Cell Therapies: Manufacturing, Efficacy, and Access
Manufacturing for Personalized Medicine: Customised Cell Products at Scale
Analytics, Potency Assays, and Rapid Release Strategies
CGTs for Monogenic Disorders: Delivering the Cure
Gene and Cell Therapies in Oncology: CAR T, NK, TCR, Oncolytic Approaches
Neurological and Neurodegenerative Disease Applications of CGTs
Market Access, Health Economics, and Reimbursement in CGT
Global Access and Equity: Bridging the CGT Innovation Gap
The Future Landscape of Cell and Gene Therapies: 2030 and Beyond
Cell and Gene Therapy Clinical Development
Cell and Gene Therapy Pipeline Analysis